Rintaro Tachi, Michiyasu Fuga, Toshihide Tanaka, Akihiko Teshigawara, Ikki Kajiwara, Koreaki Irie, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama. The white-collar sign after Neuroform Atlas stent-assisted coil embolization of unruptured intracranial aneurysms. The Neuroradiology Journal. 2024
M Fuga, T Tanaka, R Tachi, S Yamana, K Irie, I Kajiwara, A Teshigawara, T Ishibashi, Y Hasegawa, Y Murayama. Contrast Injection from an Intermediate Catheter Placed in an Intradural Artery is Associated with Contrast-Induced Encephalopathy following Neurointervention. AJNR. American journal of neuroradiology. 2023
Michiyasu Fuga, Toshihide Tanaka, Rintaro Tachi, Kyoichi Tomoto, Kenta Kazami, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama. Risk factors for radial artery occlusion after neurointervention for unruptured intracranial aneurysm via transradial access. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023. 15910199231189927-15910199231189927
Michiyasu Fuga, Toshihide Tanaka, Rintaro Tachi, Koreaki Irie, Ikki Kajiwara, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama. Efficacy and safety of fetal posterior cerebral artery stented coil embolization for fetal posterior cerebral aneurysms. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023. 15910199231188556-15910199231188556
Jun Takei, Yuko Kamata, Toshihide Tanaka, Nei Fukasawa, Kazutaka Gomisawa, Mari Satake, Ryosuke Mori, Yohei Yamamoto, Tomoya Suzuki, Ayaka Oda, et al. Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma. Cancer immunology, immunotherapy : CII. 2023
MET-2 Clinical features of renal cell carcinoma brain metastases compared with other carcinomas. 2023. 5. 5. v4-v4
IMT-1 A role of dendritic cell immunotherapy as a modality in multidisciplinary therapy for glioblastoma. 2023. 5. 5. v3-v4
ANGI-1 Regulation of alternative angiogenic factors in bevacizumab therapy for glioblastoma. 2023. 5. 5. v1-v2
Akasaki Y, Kikuchi T, Tanaka T, Murayama Y. Dendritic cell immunotherapy for malignant glioma: Research history for 25 years and the future perspectives. Neuro-Oncology Advances. 2022. 4. 3. iii27
Akasaki Y, Suzuki T, Takei J, Tanaka T, Mori R, Koseki H, Yamamoto Y, Teshigawara A, Kamata Y, Yanagisawa T, et al. Pros and cons of surgical intervention for diffuse midline glioma aimed at dendritic cell immunotherapy. Neuro-Oncology Advances. 2022. 4. 3. iii12
